中伦助力正心谷资本领投尧唐生物
尧唐生物日前宣布完成近五亿元人民币C轮融资,本轮融资由正心谷资本领投,上海国投先导等多家知名机构参与。依托其高通量编辑器挖掘和进化平台,以及非病毒载体LNP递送平台,尧唐生物致力于开发具有“一次给药、终身治愈”潜力的体内基因编辑药物。YolTech Therapeutics recently announced the closing of its approximately USD 70 million Series C financing led by Loyal Valley Capital, with participation from Shanghai SSCI Leading P...
Time:2026年08月01日 10:08:18 Read:171℃